Read More Pharma Industry News GMP psilocybin manufacturing supports growing psychedelic clinical pipeline Psyence Biomedical Ltd. exports GMP psilocybin for a Phase IIb cancer trial. Discover what this means for psychedelic medicine and biotech investors. bySoujanya RaviMarch 6, 2026